The Global Cataract Surgery Devices Market Size is projected to grow at a CAGR of 5.07% during the forecast period from 2026 to 2034 | DelveInsight 

4 August 2026

DelveInsight’s Cataract Surgery Devices Market Insights Report 2034 provides the current and forecast market analysis, individual leading Cataract Surgery Devices companies’ market shares, challenges, Cataract Surgery Devices Market Drivers, barriers, trends, and key market Cataract Surgery Devices companies in the market.

To read more about the latest highlights related to the Cataract Surgery Devices Market @ https://www.delveinsight.com/report-store/cataract-surgery-devices-market

Key Takeaways from the Cataract Surgery Devices Market Report

  • In April 2025, Alcon Inc. launched the UNITY Vitreoretinal Cataract System and the UNITY Cataract System, offering both a combined console and a standalone cataract system, featuring first-to-market technologies including UNITY 4D Phaco and the UNITY Intelligent Fluidics system. Strategic significance: Reinforces the strategic emphasis on combining advanced phaco technology with intelligent fluidics to deliver greater precision, stability, and efficiency with reduced energy use.
  • In March 2025, Alcon Inc. announced that its widely implanted Vivity extended depth-of-focus lens became available on its advanced Clareon lens material, with the Clareon Vivity receiving CE Mark approval and beginning commercial rollout across Europe in the second quarter of 2025. Strategic significance: Combines premium optical performance with a material engineered to reduce posterior capsule opacification and glistenings.
  • In October 2024, Bausch & Lomb Incorporated announced FDA approval of the enVista Envy full range of vision intraocular lens, designed to deliver improved visual outcomes for cataract patients. Strategic significance: Broadens the premium portfolio of a major manufacturer and intensifies competition in the presbyopia-correcting lens segment.
  • The cataract surgery devices market was valued at USD 9.15 billion in 2025 and is projected to reach USD 14.27 billion by 2034. Growth is supported by the growing prevalence of cataracts and vision impairment, the rising burden of lifestyle disorders that accelerate cataract development, an expanding geriatric population, and rising product development activity among key manufacturers.
  • The global cataract surgery devices market is growing at a CAGR of 5.07% during the forecast period from 2026 to 2034.
  • The principal drivers are the growing prevalence of cataracts and vision impairment; increasing prevalence of lifestyle disorders such as diabetes and hypertension; a rising geriatric population; technological advancement in surgical devices and procedures; rising product development and premiumization; the emergence of robotic-assisted and laser surgeries; and expanding healthcare access and cataract outreach.
  • The leading Cataract Surgery Devices Companies include Alcon Inc., Johnson & Johnson Services, Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG (ZEISS Group), NIDEK CO., LTD., HOYA Corporation, STAAR Surgical Company, Ziemer Ophthalmic Systems AG, Topcon Corporation, and Oertli Instrumente AG, among others.

To know more about why North America is leading the market growth in the Cataract Surgery Devices Market, Get a snapshot @ https://www.delveinsight.com/report-store/cataract-surgery-devices-market

Cataract Surgery Devices Overview 

Cataract surgery devices encompass the full range of instruments, equipment, and artificial implants used by ophthalmologists to treat cataracts, the clouding of the eye’s natural lens that is a leading cause of reversible blindness worldwide. Phacoemulsification systems use ultrasonic energy to break up and aspirate the cataractous lens through a small incision and are the mainstay of modern cataract surgery. Femtosecond lasers enable a bladeless, computer-guided approach to key surgical steps, underpinning femtosecond laser-assisted cataract surgery. Intraocular lenses are the artificial implants that replace the natural lens, spanning monofocal, toric, multifocal, and extended depth-of-focus designs, and represent the largest device category. Ophthalmic viscosurgical devices protect intraocular tissue and maintain space during surgery. The contemporary market is defined by the shift toward premium refractive cataract surgery, the adoption of femtosecond laser and robotic-assisted platforms, and the integration of artificial intelligence into surgical planning and guidance.

Cataract Surgery Devices Market Key Growth Drivers

  • Growing prevalence of cataracts and vision impairment is a foundational driver, with DelveInsight estimating that some 2.4 billion people globally are affected by near or distance vision impairment.
  • A large treatment gap underscores unmet need — only 17% of those with cataract-related impairment have access to effective intervention.
  • Rising prevalence of lifestyle disorders such as diabetes, obesity, and hypertension is accelerating the early onset of cataracts and expanding the treated population toward younger age groups.
  • A rapidly aging global population is a structural driver, with the share aged 60 and above projected to rise from 12% in 2015 to 22% by 2050, reaching 2.1 billion people.
  • Rising patient awareness and preference for premium intraocular lenses that reduce spectacle dependence and improve visual outcomes is shifting the mix toward higher-value devices.
  • Continuous technological advancement, including femtosecond laser-assisted surgery, advanced intraocular lenses, robotic-assisted platforms, and AI-driven surgical planning, is raising the value delivered per procedure.
  • Rising product development activity and regulatory approvals among leading manufacturers continue to refresh phacoemulsification and laser platforms.

Get a sneak peek at the Cataract Surgery Devices Market Dynamics @ https://www.delveinsight.com/report-store/cataract-surgery-devices-market

Cataract Surgery Devices Market Segment Analysis 

The Cataract Surgery Devices Market by Product Type (Phacoemulsification Systems, Femtosecond Lasers, Intraocular Lenses, Viscosurgical Devices, and Others), End-User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

By product type, intraocular lenses led the market with 47% share in 2025, given their role as the indispensable implant used in every cataract procedure and the premiumization trend across multifocal, trifocal, toric, and extended depth-of-focus designs. By end-user, hospitals led with 45% share in 2025, given their advanced infrastructure and access to cutting-edge technologies such as phacoemulsification systems, femtosecond lasers, and premium intraocular lenses, though ambulatory surgical centers are the fastest-growing setting. North America led global revenue with 39% share in 2025, the largest of any region, while Asia-Pacific is the fastest-growing region, defined by a high volume of procedures and significant unmet need.

Which MedTech key players in the Cataract Surgery Devices Market are set to emerge as the trendsetter explore @ https://www.delveinsight.com/report-store/cataract-surgery-devices-market

Cataract Surgery Devices Market Competitive Landscape 

The Cataract Surgery Devices market is classified as Moderately Concentrated. A few key global players, including Alcon, Johnson & Johnson Vision, Bausch + Lomb, and Carl Zeiss Meditec, dominate the market through comprehensive portfolios spanning surgical platforms, lasers, and intraocular lenses, strong brand recognition among surgeons, global distribution, and continuous research and development. These companies maintain leadership through product innovation, strategic partnerships, and geographic expansion, while specialists including NIDEK, HOYA, STAAR Surgical, Ziemer, Topcon, and Oertli compete across platforms and lenses, and emerging players offering specialized or cost-effective solutions increase competition.

Cataract Surgery Devices Companies 

Alcon Inc., Johnson & Johnson Services, Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG (ZEISS Group), NIDEK CO., LTD., HOYA Corporation, STAAR Surgical Company, Ziemer Ophthalmic Systems AG, Topcon Corporation, Oertli Instrumente AG, and others.

Cataract Surgery Devices Market Restraints 

Despite a broad and demographically durable demand base, the Cataract Surgery Devices market faces material constraints. Surgical complications, including posterior capsule opacification, cystoid macular edema, retinal detachment, infections, and refractive surprise, increase the cost and complexity of care and create caution among surgeons and patients in adopting newer technologies. Stringent and lengthy regulatory pathways raise the cost and time of introducing new devices, creating a high barrier for smaller innovators. Reimbursement structures shape the addressable market significantly, since most health systems cover standard monofocal lenses but not the substantial additional cost of premium presbyopia-correcting lenses or femtosecond laser assistance, restricting the premium market to patients able and willing to pay out of pocket. Additional constraints include the high cost of advanced surgical platforms and premium lenses, which limits penetration in cost-sensitive markets; pricing pressure from competitive markets and high-volume public procurement; and the volatility that tariffs on imported components and finished devices add to cost and supply.

Interested in knowing the Cataract Surgery Devices Market by 2034? Click to get a snapshot of the Cataract Surgery Devices Market Trends- https://www.delveinsight.com/report-store/cataract-surgery-devices-market

Scope of the Cataract Surgery Devices Market Report

  • Coverage- Global
  • Forecast Period- 2026-2034
  • Cataract Surgery Devices Companies- Alcon Inc., Johnson & Johnson Services, Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG (ZEISS Group), NIDEK CO., LTD., HOYA Corporation, STAAR Surgical Company, Ziemer Ophthalmic Systems AG, Topcon Corporation, Oertli Instrumente AG, and others.
  • Cataract Surgery Devices Market Restraints and Regulatory Analysis
  • Cataract Surgery Devices Porter Five Forces Analysis and Market Assessment

Explore more information of the Cataract Surgery Devices Market Insights @ https://www.delveinsight.com/report-store/cataract-surgery-devices-market

Table of Contents

  1. Introduction
  2. Executive Summary of Cataract Surgery Devices Market
  3. Key Factors Impacting the Cataract Surgery Devices Market
  4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
  5. Regulatory Analysis
  6. Porter’s Five Forces Analysis
  7. Cataract Surgery Devices Market Assessment
  8. Cataract Surgery Devices Market Competitive Landscape
  9. Cataract Surgery Devices Market Startup Funding and Investment Trends
  10. Company and Product Profiles
  11. Cataract Surgery Devices Market KOL Views
  12. Project Approach
  13. About DelveInsight
  14. Disclaimer and Contact Us

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Contact Us

Kanishk

info@delveinsight.com 

Leave a Reply

Your email address will not be published.

Don't Miss

Melanoma Clinical Trials

Melanoma Clinical Trials 2025: EMA, PDMA, FDA Approvals and Companies

Melanoma Companies are IO Biotech, Moderna Inc., Merck Sharp &

Huntington’s Disease Market to Witness Robust Growth at a 14% CAGR Through 2036 Amid Emergence of Disease-Modifying Gene and RNA-Based Therapies

DelveInsight’s “Huntington’s Disease Market Insights, Epidemiology, and Market Forecast –